FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 151 through 200 of 278

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
KYMR Nasdaq Kymera Therapeutics, Inc. 2830
LENZ Nasdaq LENZ Therapeutics, Inc. 2830
LEXX Nasdaq Lexaria Bioscience Corp. 2830
LFCR Nasdaq Lifecore Biomedical, Inc. 2830
LIPO Nasdaq Lipella Pharmaceuticals Inc. 2830
LLY New York Eli Lilly and Company 2830
LQDA Nasdaq Liquidia Corporation 2830
LRMR Nasdaq Larimar Therapeutics, Inc. 2830
LTRN Nasdaq Lantern Pharma Inc. 2830
LXRX Nasdaq Lexicon Pharmaceuticals, Inc. 2830
LYRA Nasdaq Lyra Therapeutics, Inc. 2830
MAZE Nasdaq Maze Therapeutics, Inc. 2830
MCRB Nasdaq Seres Therapeutics, Inc. 2830
MEIP Nasdaq MEI Pharma, Inc. 2830
MGTX Nasdaq MeiraGTx Holdings plc 2830
MGX Nasdaq Metagenomi, Inc. 2830
MIRA Nasdaq MIRA Pharmaceuticals, Inc. 2830
MIRM Nasdaq Mirum Pharmaceuticals, Inc. 2830
MIST Nasdaq Milestone Pharmaceuticals Inc. 2830
MNMD Nasdaq Mind Medicine (MindMed) Inc. 2830
MOLN Nasdaq Molecular Partners AG 2830
MRK New York Merck & Co., Inc. 2830
MTNB NYSE American Matinas BioPharma Holdings, Inc. 2830
NAGE Nasdaq Niagen Bioscience, Inc. 2830
NAMS Nasdaq NewAmsterdam Pharma Company N.V. 2830
NERV Nasdaq Minerva Neurosciences, Inc. 2830
NGNE Nasdaq Neurogene Inc. 2830
NLSP Nasdaq NLS Pharmaceutics AG 2830
NMRA Nasdaq Neumora Therapeutics, Inc. 2830
NNVC NYSE American NanoViricides, Inc. 2830
NTRB Nasdaq Nutriband Inc. 2830
NUVB New York Nuvation Bio Inc. 2830
NVO New York Novo Nordisk A/S 2830
OKUR Nasdaq OnKure Therapeutics, Inc. 2830
OMER Nasdaq Omeros Corporation 2830
OPHLY Over the counter Ono Pharmaceutical Co., Ltd. 2830
OVID Nasdaq Ovid Therapeutics Inc. 2830
PBYI Nasdaq Puma Biotechnology, Inc. 2830
PCSA Nasdaq Processa Pharmaceuticals, Inc. 2830
PCVX Nasdaq Vaxcyte, Inc. 2830
PDSB Nasdaq PDS Biotechnology Corporation 2830
PEPG Nasdaq PepGen Inc. 2830
PFE New York Pfizer Inc. 2830
PHAR Nasdaq Pharming Group N.V. 2830
PHAT Nasdaq Phathom Pharmaceuticals, Inc. 2830
PHIO Nasdaq Phio Pharmaceuticals Corp. 2830
PHVS Nasdaq Pharvaris N.V. 2830
PLRX Nasdaq Pliant Therapeutics, Inc. 2830
POAI Nasdaq Predictive Oncology Inc. 2830
PRTA Nasdaq Prothena Corporation plc 2830
Results 150 through 200 of 278